Related references
Note: Only part of the references are listed.The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL
Francesco E. Boccalatte et al.
BLOOD (2009)
Tyrosine Phosphorylation of Grb2: Role in Prolactin/Epidermal Growth Factor Cross Talk in Mammary Epithelial Cell Growth and Differentiation
Eric Haines et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Anaplastic Lymphoma Kinase (ALK)-Induced Malignancies: Novel Mechanisms of Cell Transformation and Potential Therapeutic Approaches
Mariusz A. Wasik et al.
SEMINARS IN ONCOLOGY (2009)
Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies
Itaru Matsumura et al.
CANCER SCIENCE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
The anaplastic lymphoma kinase in the pathogenesis of cancer
Roberto Chiarle et al.
NATURE REVIEWS CANCER (2008)
Pathobiology of ALK+ anaplastic large-cell lymphoma
Hesham M. Amin et al.
BLOOD (2007)
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration
Claudia Voena et al.
CANCER RESEARCH (2007)
Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells
WH Wan et al.
BLOOD (2006)
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
R Piva et al.
BLOOD (2006)
Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy
PG Dharmawardana et al.
ANTI-CANCER DRUGS (2006)
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase
C Ambrogio et al.
BLOOD (2005)
Truncated ALK derived from chromosomal translocation t(2;5)(p23;q35) binds to the SH3 domain of p85-PI3K
D Polgar et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Identification of NPM-ALK interacting proteins by tandem mass spectrometry
DK Crockett et al.
ONCOGENE (2004)
Anaplastic lymphoma kinase proteins in growth control and cancer
K Pulford et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Conditional suppression of cellular genes: Lentivirus vector-mediated drug-inducible RNA interference
M Wiznerowicz et al.
JOURNAL OF VIROLOGY (2003)
The adaptor function of SHP-2 downstream of the prolactin receptor is required for the recruitment of p29, a substrate of SHP-2
P Minoo et al.
CELLULAR SIGNALLING (2003)
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors
R Chiarle et al.
BLOOD (2003)
In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation
R Piva et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway
H Hanafusa et al.
NATURE CELL BIOLOGY (2002)
Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling
SG Li et al.
EMBO JOURNAL (2001)
Solution structure of grb2 reveals extensive flexibility necessary for target recognition
S Yuzawa et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Inhibitors of RAS signal transduction as antitumor agents
C Garbay et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
